Hunan Qianshan Pharmaceutical Machinery Co., Ltd. (hereinafter referred to as "the Company" or "Qianshan Pharmaceutical Machinery") and the Company's Chairman and General Manager Mr. Liu Xianghua, and Chief Financial Officer Mr. Zhou Dalian received the administrative supervision measures decision from the China Securities Regulatory Commission Hunan Regulatory Bureau (hereinafter referred to as "Hunan Securities Regulatory Bureau") on September 4, 2020.
The content of the administrative supervision measures decision ([2020] No. 38) "Decision on Issuing a Warning Letter to Qianshan Pharmaceutical Machinery and Relevant Responsible Persons" is as follows: